| Record ID | marc_columbia/Columbia-extract-20221130-021.mrc:69996108:1536 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-021.mrc:69996108:1536?format=raw |
LEADER: 01536cam a2200325Ii 4500
001 10203742
005 20130422130248.0
008 130220s2013 dcua b 100 0 eng d
020 $a0309265959
020 $a9780309265959
035 $a(OCoLC)ocn828139251
035 $a(OCoLC)828139251
035 $a(NNC)10203742
040 $aYDXCP$beng$erda$cYDXCP$dAZS
090 $aRC311.1$b.N53 2013
100 1 $aNicholson, Anna,$eauthor.
245 10 $aDeveloping and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis :$bworkshop summary /$cAnna Nicholson, Rebecca A. English, Rita S. Guenther, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
264 1 $aWashington, D.C. :$bNational Academies Press,$cc2013.
300 $axvii, 152 pages :$billustrations (some color) ;$c24 cm
336 $atext$2rdacontent
337 $aunmediated$2rdamedia
338 $avolume$2rdacarrier
504 $aIncludes bibliographical references (pages 111-113).
530 $aAlso issued online.
650 0 $aMultidrug-resistant tuberculosis$xPrevention$vCongresses.
650 0 $aBusiness logistics$vCongresses.
650 0 $aInternational cooperation$vCongresses.
710 2 $aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation.
856 41 $uhttp://www.nap.edu/catalog.php?record_id=13524$zView online
852 00 $boff,sci$hRC311.1$i.N53 2013g